2008 ASCO Genitourinary Cancers Symposium: Updates in the Management of Prostate and Kidney Cancers - CME
C. Dean Buckner, MD

Radiofrequency Ablation Effective for Lung Tumors (7/22/2008)
Researchers involved in a multicenter international trial have reported that the use of radiofrequency ablation for the treatment of lung cancer or pulmonary metastases provides an effective and safe therapeutic option for selected patients. These results were recently published in the July 7, 2008 issue of Lancet Oncology.

Denosumab Improves Bone Density in Prostate Cancer Patients (7/16/2008)
Amgen has reported that denosumab improved bone density and reduced the risk of vertebral fracture in men with nonmetastatic prostate cancer receiving androgen-deprivation therapy (ADT).

Study Questions Benefit of Androgen Deprivation Therapy for Localized Prostate Cancer (7/11/2008)
Researchers from the Robert Wood Johnson Medical School have reported that primary androgen deprivation therapy (PADT) may not be associated with improved survival compared with conservative management of elderly men with localized prostate cancer. The details of this study appeared in the July 9, 2008 issue of the Journal of the American Medical Association.

Salvage Radiotherapy Improves Prostate Cancer-specific Survival (6/19/2008)
Researchers from Johns Hopkins University and Duke University have reported that salvage radiotherapy following biochemical recurrence improves prostate cancer-specific survival in men with a PSA doubling time of less than six months. The details of this retrospective analysis were published in the June 18, 2008 issue of the Journal of the American Medical Association.

Radiation Therapy for Prostate Cancer Increases Incidence of AML (6/18/2008)
According to a study presented at the 2008 meeting of the American Society of Clinical Oncology, the use of external beam radiation therapy (EBRT) for treatment of prostate cancer is associated with a twofold increase in the risk of developing acute myeloid leukemia (AML).